The protective activity of adiponectin is shown in several inflammatory diseases, including cardiovascular diseases (CVDs), atherosclerosis, and insulin resistance (Daniele et al., 2011; Ouchi & Walsh, 2007; Villarreal‐Molina & Antuna‐Puente, 2012). Here, ADIPOQ is linked to atherosclerosis.